News Website

Proteomics $2.2M R&D rebate to fuel diagnostics test rollout - The Sydney Morning Herald

Proteomics $2.2M R&D rebate to fuel diagnostics test rollout The Sydney Morning Herald

Published: Nov. 12, 2025, 5:39 a.m.

Read Full Article

Advances in Targeted Therapies and Diagnostics Aim to Improve Endometriosis Treatment Options - geneonline.com

Advances in Targeted Therapies and Diagnostics Aim to Improve Endometriosis Treatment Options geneonline.com

Published: Nov. 5, 2025, 10:06 a.m.

Read Full Article

Genie Fertility Raises $1.22M to Develop Non-Invasive Uterine Diagnostics Using Menstrual Blood - Femtech Insider

Genie Fertility Raises $1.22M to Develop Non-Invasive Uterine Diagnostics Using Menstrual Blood Femtech Insider

Published: Oct. 7, 2025, 11:58 a.m.

Read Full Article

Endometriosis update: new drugs, diagnostics, subsidies & guidelines coming - The Medical Republic

Endometriosis update: new drugs, diagnostics, subsidies & guidelines coming The Medical Republic

Published: March 28, 2025, 4:21 a.m.

Read Full Article

Item of Interest: NIH announces finalists of endometriosis diagnostics competition - National Institute of Child Health and Human Development

Item of Interest: NIH announces finalists of endometriosis diagnostics competition National Institute of Child Health and Human Development

Published: March 13, 2025, 1 p.m.

Read Full Article

Global Endometriosis Treatment Market Set for Robust Growth, Projected to Reach USD 6,297.2 million by 2035 amid Advancements in Diagnostics and Emerging Targeted Therapies | FMI - Yahoo Finance

Global Endometriosis Treatment Market Set for Robust Growth, Projected to Reach USD 6,297.2 million by 2035 amid Advancements in Diagnostics and Emerging Targeted Therapies | FMI Yahoo Finance

Published: March 4, 2025, 3:30 p.m.

Read Full Article

Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ – An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. - Markets Insider

Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ – An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. Markets Insider

Published: Feb. 25, 2025, 1:10 p.m.

Read Full Article

Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ - An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. - The Manila Times

Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ - An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. The Manila Times

Published: Feb. 25, 2025, 10:48 a.m.

Read Full Article

Cicero Diagnostics, Inc. Announces the Release of - GlobeNewswire

Cicero Diagnostics, Inc. Announces the Release of GlobeNewswire

Published: Feb. 25, 2025, 10:46 a.m.

Read Full Article

Women’s Health Diagnostics Company PinkDx Raises $5M in Series A Extension, Bringing Total to $45M - Femtech Insider

Women’s Health Diagnostics Company PinkDx Raises $5M in Series A Extension, Bringing Total to $45M Femtech Insider

Published: Jan. 28, 2025, 6:37 a.m.

Read Full Article

Latest Articles

Proteomics $2.2M R&D rebate to fuel diagnostics test rollout - The Sydney Morning Herald

Advances in Targeted Therapies and Diagnostics Aim to Improve Endometriosis Treatment Options - geneonline.com

Genie Fertility Raises $1.22M to Develop Non-Invasive Uterine Diagnostics Using Menstrual Blood - Femtech Insider

Endometriosis update: new drugs, diagnostics, subsidies & guidelines coming - The Medical Republic

Item of Interest: NIH announces finalists of endometriosis diagnostics competition - National Institute of Child Health and Human Development

Global Endometriosis Treatment Market Set for Robust Growth, Projected to Reach USD 6,297.2 million by 2035 amid Advancements in Diagnostics and Emerging Targeted Therapies | FMI - Yahoo Finance

Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ – An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. - Markets Insider

Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ - An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases. - The Manila Times

Cicero Diagnostics, Inc. Announces the Release of - GlobeNewswire

Women’s Health Diagnostics Company PinkDx Raises $5M in Series A Extension, Bringing Total to $45M - Femtech Insider

Subscribe to Our Newsletter